Please enable / Bitte aktiviere JavaScript!
Veuillez activer / Por favor activa el Javascript!

“Mylan faces scrutiny over EpiPen profit data shown to Congress” plus 9 more Reuters: Health News

loading...

“Mylan faces scrutiny over EpiPen profit data shown to Congress” plus 9 more Reuters: Health News


Mylan faces scrutiny over EpiPen profit data shown to Congress

Posted: 26 Sep 2016 12:39 PM PDT

(Reuters) - Mylan NV faced questions on Monday about the profit on its EpiPen emergency allergy treatment, following a report that the company makes 60 percent more on the injector than it had told Congress.

More U.S. babies born addicted to opiates like heroin

Posted: 26 Sep 2016 02:40 PM PDT

(Reuters Health) - The proportion of U.S. babies born suffering from withdrawal syndrome after exposure to heroin or prescription opiates in utero has more than doubled in less than a decade, a study suggests.

Cancer patients may be overly optimistic about early drug trial participation

Posted: 26 Sep 2016 02:58 PM PDT

(Reuters Health) - People with cancer may overestimate the possible benefits to them of participating in an early trial of a new medicine, even after talking with a doctor about what to expect, according to a new study from the U.K.

Sanofi gets $43 mln U.S. funding to spur Zika vaccine development

Posted: 26 Sep 2016 10:03 AM PDT

(Reuters) - Sanofi SA said on Monday the U.S. Department of Health and Human Services (HHS) approved $43.18 million in funding to accelerate the development of a Zika vaccine, as efforts to prevent the infection gather momentum.

Why morning sickness may be a good thing

Posted: 26 Sep 2016 10:30 AM PDT

(Reuters Health) - For women with a history of miscarriage, experiencing nausea and vomiting during subsequent pregnancy attempts is linked to higher odds of success, a U.S. study suggests.

Kite immunotherapy drug helps blood cancer patients in study

Posted: 26 Sep 2016 02:40 PM PDT

(Reuters) - Kite Pharma Inc on Monday said its experimental CAR T-cell therapy, which helps the immune system fight cancer, was highly effective in treating aggressive non-Hodgkin lymphoma, although two deaths were related to the drug, according to interim data from a midstage trial.

Child TB deaths set to fall as Kenya launches new drugs

Posted: 26 Sep 2016 05:18 PM PDT

NAIROBI (Thomson Reuters Foundation) - More children are likely to survive tuberculosis, the leading infectious disease killer, after Kenya introduces child-friendly medicines on Oct. 1 - the first country in the world to do so.

Poor exercise habits may follow teens into adulthood

Posted: 26 Sep 2016 01:08 PM PDT

(Reuters Health) - Most American teenagers don't get enough exercise, and they often stick with their sedentary ways as they enter adulthood, a U.S. study suggests.

FDA approves J&J's autoimmune drug Stelara for Crohn's disease

Posted: 26 Sep 2016 07:13 AM PDT

(Reuters) - Johnson & Johnson said on Monday that the U.S. Food and Drug Administration approved the company's blockbuster psoriasis drug, Stelara, for use in adults with Crohn's disease.

Pfizer decides against split-up; more deals seen likely

Posted: 26 Sep 2016 11:56 AM PDT

NEW YORK (Reuters) - Pfizer Inc , which was considering splitting itself for more than two years, said on Monday it would not do so, prompting shareholders to expect more deals that could bolster its roster of new medicines.

Related Posts :